NEW YORK (GenomeWeb) – Almost seven years after the Genetic Information Nondiscrimination Act (GINA) was signed into law, it has only been cited in a limited number of cases and remains largely unknown to the majority of the US population, while concerns about gaps in its coverage and fear of discrimination persist, according to a Perspective article in The New England Journal of Medicine this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.